title: Thrombophlebitis migrans following co-trimoxazole therapy.
abstract: We report an unusual and severe vasculitic disorder following co-trimoxazole, given orally for a urinary tract infection. The vasculitis was manifest solely as thrombophlebitis migrans and involving only veins without evidence of polyarteritis nodosa, or underlying malignancy.
authors: Division of Immunological Medicine, Northwick Park Hospital, Harrow, Middlesex, UK.
authors: J
authors: J
authors: Verne-Pignatelli
authors: G P
authors: GP
authors: Spickett
authors: A G
authors: AG
authors: Dalgleish
authors: A M
authors: AM
authors: Denman
mesh_terms: D000892:Anti-Infective Agents, Urinary / Q000009:adverse effects*; D004338:Drug Combinations / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D013420:Sulfamethoxazole / Q000009:adverse effects*; D013924:Thrombophlebitis / Q000139:chemically induced*; D014295:Trimethoprim / Q000009:adverse effects*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
chemical_list: D000892:Anti-Infective Agents, Urinary; D004338:Drug Combinations; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole